These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. A procedure for wall detection in [18F]FDG positron emission tomography heart studies. Landoni C, Bettinardi V, Lucignani G, Gilardi MC, Striano G, Fazio F. Eur J Nucl Med; 1996 Jan; 23(1):18-24. PubMed ID: 8586097 [Abstract] [Full Text] [Related]
46. Clinical significance of augmented fluorine-18 deoxyglucose uptake in remote normoperfused myocardium in patients with acute coronary syndrome under fasting conditions. Nakano A, Lee JD, Shimizu H, Yonekura Y, Ueda T. J Nucl Cardiol; 2000 Jan; 7(5):454-60. PubMed ID: 11083194 [Abstract] [Full Text] [Related]
48. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Yamada N, Nishikawa J, Sasaki Y, Omata M. J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594 [Abstract] [Full Text] [Related]
49. Clinical significance of reverse redistribution on 24-hour delayed imaging of exercise thallium-201 myocardial SPECT: comparison with myocardial fluorine-18-FDG-PET imaging and left ventricular wall motion. Ohte N, Hashimoto T, Banno T, Narita H, Kobayashi K, Akita S, Fujinami T. J Nucl Med; 1995 Jan; 36(1):86-92. PubMed ID: 7799089 [Abstract] [Full Text] [Related]
50. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography. vom Dahl J, Herman WH, Hicks RJ, Ortiz-Alonso FJ, Lee KS, Allman KC, Wolfe ER, Kalff V, Schwaiger M. Circulation; 1993 Aug; 88(2):395-404. PubMed ID: 8339403 [Abstract] [Full Text] [Related]
51. Visceral adiposity is associated with altered myocardial glucose uptake measured by (18)FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes. Kim G, Jo K, Kim KJ, Lee YH, Han E, Yoon HJ, Wang HJ, Kang ES, Yun M. Cardiovasc Diabetol; 2015 Nov 04; 14():148. PubMed ID: 26538247 [Abstract] [Full Text] [Related]
52. Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes. Cusi K, Kashyap S, Gastaldelli A, Bajaj M, Cersosimo E. Am J Physiol Endocrinol Metab; 2007 Jun 04; 292(6):E1775-81. PubMed ID: 17299078 [Abstract] [Full Text] [Related]
53. Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Kobayakawa N, Aoyagi T, Sugiura S, Yamada N, Ohtomo K, Sasaki Y, Omata M, Yazaki Y. J Nucl Med; 1999 Jul 04; 40(7):1116-21. PubMed ID: 10405129 [Abstract] [Full Text] [Related]
54. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults. Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC. J Clin Endocrinol Metab; 2001 Dec 04; 86(12):5813-8. PubMed ID: 11739444 [Abstract] [Full Text] [Related]
55. [The recent studies of myocardial blood flow and metabolism by using positron emission computed tomography]. Ohtake T, Yokoyama I, Serizawa T, Nishikawa J, Sasaki Y. Kaku Igaku; 1993 Mar 04; 30(3):331-9. PubMed ID: 8479102 [Abstract] [Full Text] [Related]
56. Metabolic mismatch of septal beta-oxidation and glucose utilization in left bundle branch block assessed with PET. Altehoefer C, vom Dahl J, Bares R, Stöcklin GL, Büll U. J Nucl Med; 1995 Nov 04; 36(11):2056-9. PubMed ID: 7472598 [Abstract] [Full Text] [Related]
57. Relation between myocardial 18F-FDG uptake in the fasting state and coronary angiography in patients with coronary artery disease. Huang G, Lucignani G, Landoni C, Galli L, Paganelli G, Rossetti C, Del Sole A, Fazio F. Nucl Med Commun; 1994 May 04; 15(5):311-6. PubMed ID: 8047316 [Abstract] [Full Text] [Related]
58. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids. Pontiroli AE, Manzoni MF, Malighetti ME, Lanzi R. J Clin Endocrinol Metab; 1996 Nov 04; 81(11):3998-4001. PubMed ID: 8923850 [Abstract] [Full Text] [Related]
59. Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. Nuutila P, Knuuti MJ, Raitakari M, Ruotsalainen U, Teräs M, Voipio-Pulkki LM, Haaparanta M, Solin O, Wegelius U, Yki-Järvinen H. Am J Physiol; 1994 Dec 04; 267(6 Pt 1):E941-6. PubMed ID: 7810638 [Abstract] [Full Text] [Related]
60. The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers. Berry JJ, Baker JA, Pieper KS, Hanson MW, Hoffman JM, Coleman RE. J Nucl Med; 1991 Aug 04; 32(8):1518-25. PubMed ID: 1869972 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]